Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,365 | -63,323 | -70,641 | -42,935 | -16,706 |
| Depreciation Amortization | 7,654 | 8,890 | 7,149 | 4,792 | 3,815 |
| Income taxes - deferred | 4 | -51 | 35 | -155 | 7 |
| Accounts receivable | 2,300 | -7,265 | -285 | -2,974 | 6,697 |
| Accounts payable and accrued liabilities | -3,017 | 1,148 | 1,193 | 4,361 | -3,045 |
| Other Working Capital | -11,844 | -12,058 | 2,164 | -4,561 | 2,394 |
| Other Operating Activity | 16,165 | 21,760 | 6,889 | 5,404 | -5 |
| Operating Cash Flow | $-44,103 | $-50,899 | $-53,496 | $-36,068 | $-6,843 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,595 | 7,000 | -6,774 | N/A | 10,168 |
| PPE Investments | -2,456 | -3,653 | -7,305 | -5,094 | -3,295 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -145 |
| Investing Cash Flow | $-24,051 | $3,347 | $-14,079 | $-5,094 | $6,728 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 11,250 | 31,250 | N/A | 34,976 |
| Debt Repayment | -1,022 | -676 | -621 | -322 | -25,191 |
| Common Stock Issued | 91 | 346 | 447 | 138,947 | 122 |
| Other Financing Activity | -2,274 | 45,924 | -2,350 | -1,590 | -4,421 |
| Financing Cash Flow | $-3,205 | $56,844 | $28,726 | $137,035 | $5,486 |
| Beginning Cash Position | 83,824 | 74,532 | 113,381 | 17,508 | 12,137 |
| End Cash Position | 12,465 | 83,824 | 74,532 | 113,381 | 17,508 |
| Net Cash Flow | $-71,359 | $9,292 | $-38,849 | $95,873 | $5,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,103 | -50,899 | -53,496 | -36,068 | -6,843 |
| Capital Expenditure | -2,456 | -3,653 | -7,360 | -5,094 | -3,295 |
| Free Cash Flow | -46,559 | -54,552 | -60,856 | -41,162 | -10,138 |